Crescent Biopharma grants inducement stock options for 23,550 shares at $17.57 each

Crescent Biopharma

Crescent Biopharma

CBIO

0.00
  • Crescent Biopharma granted options covering 23,550 ordinary shares to two non-executive employees under its 2025 Employment Inducement Incentive Award Plan.
  • Options carry a 10-year term with an exercise price of USD 17.57, set at the June 10 Nasdaq closing price.
  • Vesting starts with 25% on the first anniversary of each employee’s start date, then monthly in equal installments.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Crescent Biopharma Inc. published the original content used to generate this news brief on June 11, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.